AnalystsStan Berenshteyn
Stan Berenshteyn's Stock Forecasts

Analyst Ranking
Bottom 4%
#5112 out of 5298 analysts
Average Return
-9.57%
Win Rate
45%25 out of 56
Risk vs Reward
Poor
Good

Stan Berenshteyn's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
American Well CorpAMWL
+88.62%$4.57$8.62
2025-11-04 -
2026-06-16
Strong Buy
Omnicell IncOMCL
+55.01%$28.23$43.76
2025-05-22 -
2026-05-21
Strong Buy
Accolade IncACCD
+53.41%$13.80$6.43
2022-04-10 -
2022-05-02
Strong Sell
Omnicell IncOMCL
+51.58%$62.87$30.44
2023-07-19 -
2023-11-03
Strong Sell
Omnicell IncOMCL
+50.26%$28.73$43.17
2025-05-13 -
2026-05-13
Strong Buy

Stan Berenshteyn Analyst Color

Get additional color on Stan Berenshteyn's coverage of popular stocks

Stan Berenshteyn's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Veeva Systems IncVEEV
11Strong Buy$320.00+95.86%Maintains
13 days ago
Phreesia IncPHR
3Hold$9.00-4.66%Downgrades
a month ago
Doximity IncDOCS
16Hold$18.00-13.83%Downgrades
a month ago
Omada Health IncOMDA
2Hold$18.00+5.20%Maintains
a month ago
Hinge Health IncHNGE
2Strong Buy$80.00+17.98%Maintains
a month ago
Omnicell IncOMCL
19Strong Buy$55.00+37.84%Maintains
2 months ago
Claritev CorpCTEV
3Hold$22.00-28.27%Maintains
3 months ago
Health Catalyst IncHCAT
8Hold$1.00-43.82%Downgrades
3 months ago
Goodrx Holdings IncGDRX
9Strong Buy$3.50+28.21%Maintains
3 months ago
Teladoc Health IncTDOC
4Hold$6.00-20.74%Maintains
4 months ago
Waystar Holding CorpWAY
2Strong Buy$36.00+95.87%Maintains
4 months ago
American Well CorpAMWL
5Strong Buy$9.00+4.41%Maintains
7 months ago
Healthequity IncHQY
9Strong Buy$125.00N/AMaintains
a year ago
Accolade IncACCD
10Hold$6.00N/AMaintains
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.